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Background: Binge eating disorder (BED) is the most common eating disorder in the United 
States, it is more prevalent than Anorexia Nervosa and Bulimia combined. BED is characterized 
by recurrent episodes of binge eating accompanied by feeling a lack of control and marked 
distress over one’s eating behaviors. BED is a serious condition that impairs health-related 
quality of life (HRQL) and increases health care costs. 
Purpose: The purpose of this project was to identify patients at risk for binge eating disorder at 
an outpatient weight loss clinic using the validated BEDS-7 screening tool.  
Evidence-based Intervention: The 7-item Binge-Eating Disorder Screener (BEDS-7), a brief 
screener for BED, can assist providers in identifying patients who may have BED providing 
evidence-based treatment options and/or referrals for additional assessment and potential 
diagnosis of BED. 
Evaluation/Results: Screening for binge eating was conducted on all new patients seeking 
weight loss at the clinic over a 3-month period. Patients who screened positive for binge eating 
according to the BEDS-7 screening tool were provided with evidence-based treatment options 
including both pharmacological treatment and referral for psychotherapy and counseling.  
Implications for Practice: Screening for Binge eating promotes recognition of binge eating 
habits in patients undergoing weight loss treatment and awareness about binge eating and its 
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Background 
     Binge Eating Disorder (BED) is the most common eating disorder in the United States 
compared to Anorexia and Bulimia. Binge eating disorder is characterized by recurrent episodes 
of binge eating involving consumption of an amount of food that is significantly larger than most 
people would consume in a similar amount of time or under similar circumstances. Binge eating 
disorder also features a sense of lack of control over eating during the binge episodes, significant 
psychological distress such as shame or guilt about binge eating. A sense of loss of control 
during binge episodes is the core feature of BED. Binge eating is not associated with frequent 
inappropriate compensatory behavior, such as purging and excessive exercise. (National Eating 
Disorders Association, 2016)   
An estimated 2.8 million people have BED. Binge eating disorder affects approximately 
3.5 percent of women, 2 percent of men. Thirty percent of people seeking weight loss treatment 
exhibit symptoms of BED (American Psychological Association [APA], 2012) Binge eating 
disorder is most common among women and is seen in all age groups, races and income levels. It 
typically emerges in early adulthood but may surface in adolescence and persist well beyond 
midlife (Binge Eating Disorder Association, 2016.) In May 2013, the American Psychiatric 
Association (APA) recognized BED as a distinct eating disorder in Diagnostic and Statistical 
Manual of Mental Disorders, 5th Edition (DSM-5) eliminating the designation of BED as a 
provisional diagnosis.  
Binge eating disorder has been associated with psychiatric comorbidity as well as health 
and psychosocial impairment. Binge eating disorder has been shown to increase the risk of 
diabetes, obesity, hypertension, hyperlipidemia, heart disease, osteoarthritis and sleep apnea. 
Patients with BED can also suffer from anxiety, depression, low self-esteem or other issues that 
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can greatly affect quality of life. Early identification and treatment of binge eating may prevent 
progression and reduce the risk of chronic health consequences. Binge eating behavior is often 
overlooked and treatment commonly focuses on obesity and its implication as the presenting 
problem rather than addressing the core eating psychopathology. It is especially crucial to assess 
and screen for BED in primary care. Individuals with binge eating tend to utilize more health 
care services than individuals who do not have the disorder. Primary care providers play a 
pivotal role in screening, treating and referring patients for specialty treatment (Brownley et al., 
2016). 
Treatment of BED aims to reduce binge eating frequency and disordered eating, improve 
metabolic health and weight, and regulate mood. Treatment approaches include psychological 
and behavioral treatment, pharmacologic treatment, and combinations of the two approaches. Of 
the pharmacologic approaches, the anti-epileptic drug Topiramate has been found to be useful in 
BED with obesity, decreasing weight and obsessive-compulsive eating pathology as well as 
eating impulsivity. According to Brownley et al. (2016), Topiramate was associated with greater 
reductions in binge eating and produced greater increases in cognitive restraint and reductions in 
hunger, disinhibition and impulsivity (Brownley et al. 2016). 
Purpose/Aims 
The aim of this evidence-based project is to determine the prevalence of patients at risk 
for BED by screening for binge eating in patients undergoing a weight loss program. The goal is 
to identify patients at risk and provide them with adequate support and referrals. The purpose of 
the project is to increase awareness regarding eating habits and its effects on weight gain or 
inability to lose weight. According to Zwaan (2010), the prevalence of BED has been found to be 
30 percent in individuals who seek weight control treatment. Evidence recommends that 
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treatment for patients who binge eat should be directed at the disordered eating and associated 
psychopathology. Undetected and untreated BED can have significant negative implications for 
health given that it is associated with continued weight gain. Individuals engaging in high-
frequency binge eating may continue to gain weight even when concurrently participating in 
weight management treatment (Zwaan, 2010). 
Literature Review 
     A comprehensive literature review was conducted to identify articles published 
between 2009 and 2017. Literature has focused solely on Anorexia and Bulimia as the core 
eating disorders and with a lack of literature on binge eating and its effects. Search engines used 
included CINAHL, PubMed, Science Direct, Ovid online databases and Cochrane database for 
systematic reviews. Key terms used for searching engines included binge eating disorder, binge 
eating, screening for binge eating and treatment for binge eating. A total of 20 articles were 
reviewed, all of which were relevant, with a total of 6 articles used to support the evidence-based 
project.  
Amianto, Ottone, Abbate, & Fassino (2016), conducted a systematic review and meta-
analysis looking at 10 articles focusing on the prevalence of binge eating disorder in patients 
with obesity. The prevalence of BED was found to be at 30 percent in individuals seeking weight 
control treatment. Binge eating disorder was found to be more equal in gender ratio (65 percent 
female, 35 percent male) than in Bulimia Nervosa, for which only about 10 percent of persons 
affected are men. Approximately 30 percent of those participating in weight loss programs and 
70 percent of individuals in Overeaters Anonymous display BED. The studies also found a 
positive correlation between binge eating severity and degree of obesity. Binge eating obese had 
an earlier onset of obesity than non-binge eating obese, started dieting at an earlier age, started 
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worrying about their weight at an earlier age, reported a higher prevalence of marked weight 
fluctuations in the past and spent more time during adulthood trying to lose weight.  
Dorflinger, Ruser, & Masheb (2017), conducted a prospective cohort study looking at the 
prevalence of binge eating disorder in veterans referred to a primary care-based weight 
management program. The sample size consisted of 116 veterans with an average BMI of 37.9. 
Eighty-nine percent were male, and eleven percent were female. Frequency of binge eating 
ranged from zero to 21 episodes per week. All participants completed the Questionnaire of 
Eating and Weight patterns, a validated tool to screen for binge eating. The prevalence of BED 
was 7.76 percent. According to this article, BED is associated with medical and psychiatric 
conditions commonly seen and managed in primary care. The disorder typically goes undetected 
and untreated as there are a lack of assessment tools for use in primary care.   
According to Dorflinger et al. (2017), primary care providers often do not recognize the 
presence of binge eating in their patients and binge eating is rarely assessed in primary care. 
Individuals who binge eat are at a higher risk of medical comorbidities that are commonly seen 
and treated in primary care, such as metabolic syndrome and cardiovascular disorders, and report 
higher rates of disability and impairment. It is crucial that primary care practitioners screen for 
this disorder and provide patients with appropriate treatment and referrals.  
Zwaan (2010) conducted a systematic review exploring the evidence on the efficacy of 
binge eating treatment modalities. The study concluded that eating disorder treatments such as 
cognitive behavioral therapy or interpersonal psychotherapy improve binge eating with 
abstinence rates of about 50 percent. Antidepressants were also found to be successful in 
reducing binge eating frequency. The study also looked at self-help as a treatment option. Self-
help is less costly compared to psychotherapy and may help facilitate the dissemination of 
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treatment to a wider population of individuals. Self-help can be conducted in various modes 
including group format, online, by video, and by telephone making it easily accessible. 
Abstinence rates of 40-50 percent could be achieved after 8-12 weeks of working with a self-
help manual.  
A systematic review and meta-analysis conducted by Brownley et al., (2016) analyzed 34 
trials and determined that therapists-led cognitive behavioral therapy, lisdexamfetamine, second 
generation antidepressants (mainly selective serotonin reuptake inhibitors) and Topiramate were 
effective in decreasing binge-eating frequency, increased binge-eating abstinence and improved 
other eating-related psychological outcomes. Topiramate and lisdexamfetamine were effective in 
reducing weight in adults with binge eating disorder.   
Brewerton (2000), conducted a systematic review of the evidence on the diagnosis and 
treatment options for BED. The study analyzed 15 articles pertaining to the medical and 
psychiatric comorbidity associated with BED. Medical conditions associated with BED included 
higher mortality and morbidity from adult-onset (type 2) diabetes mellitus, obesity, 
hyperlipidemias, cardiovascular diseases, several cancers and sleep apneas. The disease 
prevalence increases as body mass index (BMI) increases. Binge eating occurs in a subset of 
obese patients in response to emotional stress, a phenomenon known as ‘emotional eating’. 
Patients with binge eating disorder were found to be more likely to over-eat in response to 
negative emotional states and were also found to have higher rates of anxiety, major depression, 
post-traumatic stress disorder and impulsive disorders such as compulsive buying and 
kleptomania. The study concluded that cognitive behavioral therapy and pharmacological 
therapy with antidepressants and Topiramate are effective in treating BED.  
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Perkins, Murphy, Schmidt, & Williams, (2009) conducted a systematic review of 15 
studies and evaluated the effectiveness of pure self-help and guided self-help interventions for 
BED. These treatment modalities have some utility as a first step treatment and have potential as 
an alternative to formal therapist-delivered psychological therapy. These forms of therapy for 
BED allow treatments with proven efficacy to be accessed with minimum delay. They were also 
found to be popular and acceptable to many patients and cost associated was low. Patients found 
these options attractive as they avoid the stigma or embarrassment of formal psychotherapy. 
Patients with BED are often ashamed of their disorder and find it hard to confide in a therapist 
about their symptoms. The pure self-help and guided self-help allow patients to work in their 
own time and pace. Patients reported a sense of empowerment and thus promoted collaboration. 
These treatments are flexible as, they allow patient to renew or update treatments as often as they 
wish. They are also important in reinforcing and consolidating information about BED and can 
be used to focus on teaching patients about this disorder, health implications, and better eating 
habits.  
The Agency for Healthcare Research and Quality [AHRQ] (2015) conducted a systematic 
review of evidence on the effectiveness of binge eating treatments and to help patients make 
informed choices among treatment alternatives. Therapist-led cognitive behavioral therapy was 
found to reduce binge eating frequency and increase binge eating abstinence. Eight randomized 
controlled trials (RCTs) (all placebo controlled) examined the effectiveness of antidepressants 
for treating BED patients. As a class, antidepressants were associated with better binge-eating 
outcomes than placebo, abstinence, reduction in frequency of binge episodes per week. They 
were also associated with greater reductions in eating related obsessions and compulsions. Three 
placebo-controlled RCTs provided evidence about treating BED patients with anticonvulsants, 
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specifically Topiramate. Topiramate was associated with abstinence among a greater percentage 
of participants and with greater reductions in binge eating, obsessions and compulsions related to 
binge-eating and weight. It also produced greater increases in cognitive restraint and reductions 
in hunger, disinhibition, and impulsivity.  
Methods 
   The purpose of this project was to determine the prevalence of being at risk for BED in 
patients undergoing weight loss management at a non-insurance-based weight loss clinic. The 
first step was to look at how the clinic screened patients for BED on intake. Pre-intervention 
intake forms, given to all new patients at the clinic, asked patients if they binge eat and if so 
when and with what food. Out of the 100 clinic charts, 20 percent were found to be positive for 
BED, with 1 in 5 patients stating that they binge eat based on the three questions asked on intake. 
This initial pre-intervention data suggested the need to provide more thorough BED screening 
and to provide these patients with evidence-based treatment recommendations, support and 
referrals.  
The project included screening patients at the weight loss clinic for binge eating using the 
Binge Eating Disorder Screener-7 (BEDS-7). This is a validated patient-reported screening tool 
designed to identify individuals with probable BED for further evaluation or referral to 
specialists. This screener was developed based on the DSM-5 diagnostic criteria for binge eating 
and is intended for screening use only and should not be used as a diagnostic tool. According to 
Herman et al. (2016), the seven BEDS item (BEDS-7) yielded 100 percent sensitivity and 38.7 
percent specificity when used on 97 participants in a noninterventional study. Sixteen were 
diagnosed with BED (16 percent female; 17 percent male). The study concluded that 
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implementation of the screener in clinical practice would promote better understanding of BED 
characteristics and help practitioners identify patients who may have BED for further treatment.   
The BEDS-7 screener consists of 7 questions (See Appendix H). Each question assesses 
the patient’s eating patterns and behaviors over the last 3 months. If a patient answers “YES” to 
question 1, the clinician should continue with questions 2 through 7. If the patient answers “NO” 
to question 1, there is no need to proceed with the remainder of the screener. If the patient 
answered “YES” to question 2 and checked one of the boxes which assessed how often a patient 
engaged in a behavior; sometimes, often, always for all questions 3 through 7, follow-up 
discussion of the patient’s eating behaviors and his or her feelings about those behaviors should 
be considered. Step 3 of the screener included evaluating the patient based upon the complete 
DSM-5 diagnostic criteria for BED.  
The second phase of the project included treatment recommendations for patients who 
screened positive for binge eating. This included self-help, determining patient interest in 
pharmacological treatment especially with Topiramate, and referrals to psychotherapy or support 
groups. Patients were asked to choose a preference of what might work best for them. Handouts 
with a brief description of BED and the three treatment options were given to patients at risk 
(See Appendix H). According to Perkins et al., (2009), self-help treatments in BED aim to 
improve clinical outcome as well as provide information by teaching patients relevant skills to 
overcome and manage this disorder. Self-help treatments have shown efficacy, can be accessed 
with minimum delay and are acceptable to many patients. The self-help option consisted of free 
online modules and self-help programs for BED with a psychotherapist and an eating disorder 
specialist as well as an online training for mindful eating for BED. These were free of charge and 
the patient could do them at their own pace. The purpose of the self-help option was to teach 
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patients better eating habits, to teach them how to recognize their triggers, and to educate them 
on the health impact of BED.   
Of the pharmacological options available in treating binge eating disorder, Topiramate 
has been found to be useful in BED with obesity, decreasing weight and obsessive-compulsive 
eating pathology, as well as eating impulsivity. It has been shown to reduce hunger, promote 
weight loss and reduce binge episodes and impulsivity. Topiramate was associated with 
abstinence and with greater reductions in binge eating, obsessions and compulsions related to 
binge-eating, and weight; it also produced greater increases in cognitive restraint and reductions 
in hunger, disinhibition, and impulsivity. (AHRQ, 2015) Pharmacological therapy in BED is 
specifically focused on the reduction of eating impulsiveness, binges and negative feelings. Data 
were not sufficient to recommend pharmacotherapy as single first-line therapy however, 
medications do play an important role in BED management.  
The referrals option included both online and in class support groups as well as referrals 
to psychotherapists. The class support groups included organizations such as Compulsive Eaters 
Anonymous and Overeaters Anonymous which provided face to face or telephone meetings as 
well as group meetings. Online support groups were available through social media and other 
popular support group platforms. Patients who scored positive on the screener were educated on 
BED, the signs and symptoms, risk factors and health implications. Treatment options were 
discussed with each patient and they were asked to choose a treatment preference based on what 
would ideally work the best for them stressing the importance of compliance. 
Results 
  A total of forty-four patients were screened for binge eating disorder. Thirty patients 
screened positive for being at risk for BED with a score of 2-6 on the BEDS-7 Screener. A score 
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of 2-3 were considered mildly at risk of BED, a score of 4-5 were determined to be moderately at 
risk for BED, and a score of 6 indicated severely at risk for BED. Eight patients were in the mild 
category, 10 patients were moderate, and 9 patients were in the severe category. Demographics 
for the patients included an average age of 47.2 years old. 89 percent were female, 11 percent 
were male, 73 percent were Caucasian, 20 percent were Hispanic, and 7 percent were Asian.  
As illustrated in Figure 1, the prevalence of being at risk for BED in this clinic was found 
to be 52 percent which surpasses the results of APA at 30 percent of those seeking weight 
management. (APA, 2012).  
 
 
Figure 1: This figure illustrates the prevalence of BED at this clinic as compared to the 
results from a study conducted by the American Psychological Association (APA) 
  
The mean body mass index (BMI) at the beginning of the project was 30.7 which falls 
into obese category. The BMI was calculated 1 month after the screening intervention had been 
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which falls in the overweight category indicating that these patients did lose weight a month after 
starting the weight loss program and after being screened for BED. The average weight loss of 
the patients who screened positive for being at risk for BED was 2 pounds compared to 2.9 
pounds for those patients who scored negative on the screener indicating the possibility that 
patients with BED have a slightly harder time losing weight compared to those patients who do 
not have BED.  
Comorbidities were also compared in those patients with BED and those without BED to 
determine if there was an increase in comorbidities associated with BED and if these patients had 
a difficult time losing weight. Only a few of the patients at this clinic had major comorbidities, 
specifically, the metabolic syndromes of diabetes mellitus, hypertension, hyperlipidemia and 
heart disease. Only 6 out of the 44 patients were found to have either diabetes mellitus, 
hypertension or hyperlipidemia. There were no patients with heart disease. These patients lost 
the same amount of weight as their counterparts. Patients with the above comorbidities did not 
score higher or lower on the BEDS-7 screener.  
 As outlined in Figure 2, the treatment preferences for BED, 63 percent chose the self-
help option, 32 percent chose medications specifically Topiramate, and 5 percent chose referrals. 
The patients who chose the self-help option preferred this mode of treatment due to its ease of 
access.  
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                   Figure 2: This figure illustrates the patient treatment preferences for BED 
 
This project concluded that BED is prevalent in those seeking weight loss at this clinic. 
Twenty-seven of the total patients screened preferred the self-help option which allowed them 
control over their management of this disorder. Fourteen patients were interested in Topiramate 
as a treatment option, and only 2 chose referrals to support groups and psychotherapy.   
Cost Benefit Analysis 
Binge eating disorder is a serious health serious condition that impairs health-related 
quality of life (HRQL) and increases health care costs. Evidence shows that patients with BED 
have higher health care costs compared to patients who do not. Per year health care cost for 
patients with BED is estimated at $33,000 compared to $19,000 in patients without BED (Binge 
Eating Disorder Association, 2016). Patients who seek help with BED may reduce their overall 
health care costs. Since this was a screening project which included recommendations for 
treatment, no cost was charged to the patients for the screening as this was provided cost free by 
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handout was given to all patients at no charge. The clinic did not incur any costs associated with 
screening these patients. Patients seeking weight loss at this clinic pay for their treatments out of 
pocket, as it is not an insurance-based clinic. Future considerations include the potential financial 
cost of Topiramate, as this project only focused on assessing the interest in Topiramate in those 
patients who screened positive for BED.   
Discussion 
The prevalence of being at risk for BED in this weight loss clinic is 52 percent, which is 
significantly higher than other patients seeking weight loss. The prevalence of being at risk for 
BED demonstrates the need for increased screening methods in primary care settings. The 7-item 
Binge-Eating Disorder Screener (BEDS-7), a brief screener for BED, can assist practitioners in 
identifying patients who may have BED and making the necessary follow-up decisions related to 
patient referrals or additional assessment and potential diagnosis of BED. Providers can easily 
identify those patients at risk for binge eating disorder and provide them with the appropriate and 
evidence-based treatments, referrals and follow up. Screening patients for BED helps promote a 
better understanding of binge eating habits and raises awareness of its overall impact on health 
and quality of life.   
Implications for Practice 
Binge eating disorder has been linked with several comorbid health conditions, including 
diabetes, hypertension, stroke, and heart disease, and other psychiatric illnesses such as anxiety 
and depression. It is prevalent in patients seeking weight loss management and is likely to be 
prevalent in primary care settings. The condition is significantly under diagnosed despite it being 
the most common eating disorder in the United States and is more prevalent than anorexia and 
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bulimia combined. Health care practitioners can be influential in ensuring that patients are 






























Agency for Healthcare Research and Quality. (2015). Management and outcomes of Binge-
Eating Disorder. Comparative Effectiveness Review, 160, 1-1234. Retrieved from 
www.effectivehealthcare.ahrq.gov/reports/final.cfm 
American Psychological Association. (2012). APA Practice Guidelines: Treatment of Patients 
with Eating Disorders, 3rd Edition. APA Practice Guidelines. Retrieved from 
https://psychiatry.org/psychiatrists/practice/clinical-practice-guidelines 
Amianto, F., Ottone, L., Abbate, D., & Fassino, S. (2016). Binge-eating disorder diagnosis and 
treatment: A systematic review and meta-analysis. Internal Journal of Eating Disorders, 
15, 905-919. https://doi.org/doi:10.1186/s12888-015-0445-6 
Binge Eating Disorder Association. (2016). https://bedaonline.com/ 
Brewerton, T. D. (2000, May). Binge eating disorder: Diagnosis and treatment options. CNS 
Drugs, 11, 351-361. https://doi.org/1172-7047/99/0005-0351 
Brownley, K. A., Berman, N. D., Peat, C. M., Lohr, K. N., Cullen, K. E., Bann, C. M., & Bulik, 
C. M. (2016, September 20). Binge-Eating Disorder in Adults: A Systematic Review and 
Meta-analysis. Annals of Internal Medicine, 165, 409-420. https://doi.org/10.7326/M15-
2455 
Brownley, K. A., Berkman, N. D., Sedway, J. A., Lohr, K. N. and Bulik, C. M. (2007), Binge 
eating disorder treatment: A systematic review of randomized controlled trials. 
International Journal of Eating Disorders. 40: 337–348. doi:10.1002/eat.20370 
Dorflinger, L. M., Ruser, C. B., & Masheb, R. M. (2017, March 30). A brief screening measure 
for binge eating in primary care. Eating Behaviors, 26, 163-166. https://doi.org/10.1016 
SCREENING FOR BINGE EATING DISORDER IN PATIENTS 18 
 
Herman, B. K., Deal, L. S., DiBenedetto, D. B., Nelson, L., Fehnel, S. E., & Brown, M. (2016). 
Development of the 7-Item Binge-Eating Disorder Screener (BEDS-7) []. The Primary 
Care Companion for CNS Disorders, 18(2). https://doi.org/10.4088/PCC.15m01896 
Linardon, J., Brennan, L., & de la Piedad Garcia, X. (2016). Rapid response to eating disorder 
treatment: A systematic review and meta-analysis. International Journal of Eating 
Disorders, 49(10), 905-919. doi:10.1002/eat.22595 
National Eating Disorders Association. (2016). https://www.nationaleatingdisorders.org/ 
Perkins, S. S., Murphy, R. R., Schmidt, U. U., & Williams, C. (2009). Self-help and guided self-
help for eating disorders. Cochrane Database of Systematic Reviews, 3(1), 1-82. 
https://doi.org/10.1002/14651858.CD004191.pub2 
Pollert, G. A., Engel, S. G., Schreiber-Gregory, D. N., Crosby, R. D., Cao, L., Wonderlich, S. A., 
& ... Mitchell, J. E. (2013). The role of eating and emotion in binge eating disorder and 
loss of control eating. International Journal of Eating Disorders, 46(3), 233-238. 
doi:10.1002/eat.22061 
Zwaan, M. D. (2010). Binge eating disorder and obesity. International Journal of Obesity, 25, 
51-55. 
 
 
